Status:
COMPLETED
Sensing Physical Activity to Evaluate and Monitor a Routine Aftercare Program (SensE-M)
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
Kliniken Valens
Conditions:
Disease With a Risk for Chronicity
Eligibility:
All Genders
18+ years
Brief Summary
Conditions such as multiple sclerosis (MS) and cardiovascular diseases (CVDs) are severe and prevalent health conditions which decrease life expectancy and increase morbidity. Key symptoms of MS and C...
Detailed Description
Primary hypothesis (hypothesis 1 - effective integration): The investigators hypothesize that integrating the Fitbit effectively into the program to measure activity goals will support program partici...
Eligibility Criteria
Inclusion
- Inclusion criteria are:
- Female and male inpatients who are for an inpatient stay at Kliniken Valens and participate in the 'Bliib dra'-program while the study is ongoing. The 'Bliib dra'-program is conceptualized for adult persons who have a diagnosis of MS, a cardiovascular disease, diabetes, stroke, or hypertension.
- Provision of written informed consent
Exclusion
Key Trial Info
Start Date :
February 21 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2022
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT05243407
Start Date
February 21 2022
End Date
August 30 2022
Last Update
April 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kliniken Valens
Valens, Switzerland